136 related articles for article (PubMed ID: 38712572)
1. Is there a link between talcum powder, oxidative stress, and ovarian cancer risk?
Saed GM
Expert Rev Anticancer Ther; 2024 Jul; 24(7):485-491. PubMed ID: 38712572
[TBL] [Abstract][Full Text] [Related]
2. Molecular Basis Supporting the Association of Talcum Powder Use With Increased Risk of Ovarian Cancer.
Fletcher NM; Harper AK; Memaj I; Fan R; Morris RT; Saed GM
Reprod Sci; 2019 Dec; 26(12):1603-1612. PubMed ID: 30819054
[TBL] [Abstract][Full Text] [Related]
3. Talc, body powder, and ovarian cancer: A summary of the epidemiologic evidence.
Wentzensen N; O'Brien KM
Gynecol Oncol; 2021 Oct; 163(1):199-208. PubMed ID: 34366148
[TBL] [Abstract][Full Text] [Related]
4. Talcum powder induces malignant transformation in normal human primary ovarian epithelial cells.
Harper AK; Wang X; Fan R; Kirsch Mangu T; Fletcher NM; Morris RT; Saed GM
Minerva Obstet Gynecol; 2023 Apr; 75(2):150-157. PubMed ID: 34825792
[TBL] [Abstract][Full Text] [Related]
5. Genital talc exposure and risk of ovarian cancer.
Cramer DW; Liberman RF; Titus-Ernstoff L; Welch WR; Greenberg ER; Baron JA; Harlow BL
Int J Cancer; 1999 May; 81(3):351-6. PubMed ID: 10209948
[TBL] [Abstract][Full Text] [Related]
6. Talc powder and ovarian cancer: what is the evidence?
Micha JP; Rettenmaier MA; Bohart R; Goldstein BH
Arch Gynecol Obstet; 2022 Oct; 306(4):931-933. PubMed ID: 35348830
[TBL] [Abstract][Full Text] [Related]
7. Asbestos in commercial cosmetic talcum powder as a cause of mesothelioma in women.
Gordon RE; Fitzgerald S; Millette J
Int J Occup Environ Health; 2014 Oct; 20(4):318-32. PubMed ID: 25185462
[TBL] [Abstract][Full Text] [Related]
8. Association Between the Frequent Use of Perineal Talcum Powder Products and Ovarian Cancer: a Systematic Review and Meta-analysis.
Woolen SA; Lazar AA; Smith-Bindman R
J Gen Intern Med; 2022 Aug; 37(10):2526-2532. PubMed ID: 35112281
[TBL] [Abstract][Full Text] [Related]
9. Application of talcum powder, trichloroacetic acid and silver nitrate in female rats for non-surgical sterilization: evaluation of the apoptotic pathway mRNA and miRNA genes.
Yumrutas O; Kara M; Atilgan R; Kavak SB; Bozgeyik I; Sapmaz E
Int J Exp Pathol; 2015 Apr; 96(2):111-5. PubMed ID: 25885949
[TBL] [Abstract][Full Text] [Related]
10. Perineal use of talcum powder and endometrial cancer risk.
Karageorgi S; Gates MA; Hankinson SE; De Vivo I
Cancer Epidemiol Biomarkers Prev; 2010 May; 19(5):1269-75. PubMed ID: 20406962
[TBL] [Abstract][Full Text] [Related]
11. Talcum powder, chronic pelvic inflammation and NSAIDs in relation to risk of epithelial ovarian cancer.
Merritt MA; Green AC; Nagle CM; Webb PM; ;
Int J Cancer; 2008 Jan; 122(1):170-6. PubMed ID: 17721999
[TBL] [Abstract][Full Text] [Related]
12. Perineal application of talc and cornstarch powders: evaluation of ovarian cancer risk.
Whysner J; Mohan M
Am J Obstet Gynecol; 2000 Mar; 182(3):720-4. PubMed ID: 10739536
[TBL] [Abstract][Full Text] [Related]
13. Genital powder use and risk of ovarian cancer: a pooled analysis of 8,525 cases and 9,859 controls.
Terry KL; Karageorgi S; Shvetsov YB; Merritt MA; Lurie G; Thompson PJ; Carney ME; Weber RP; Akushevich L; Lo-Ciganic WH; Cushing-Haugen K; Sieh W; Moysich K; Doherty JA; Nagle CM; Berchuck A; Pearce CL; Pike M; Ness RB; Webb PM; ; ; Rossing MA; Schildkraut J; Risch H; Goodman MT;
Cancer Prev Res (Phila); 2013 Aug; 6(8):811-21. PubMed ID: 23761272
[TBL] [Abstract][Full Text] [Related]
14. Personal and environmental characteristics related to epithelial ovarian cancer. II. Exposures to talcum powder, tobacco, alcohol, and coffee.
Whittemore AS; Wu ML; Paffenbarger RS; Sarles DL; Kampert JB; Grosser S; Jung DL; Ballon S; Hendrickson M
Am J Epidemiol; 1988 Dec; 128(6):1228-40. PubMed ID: 3195564
[TBL] [Abstract][Full Text] [Related]
15. Association of Powder Use in the Genital Area With Risk of Ovarian Cancer.
O'Brien KM; Tworoger SS; Harris HR; Anderson GL; Weinberg CR; Trabert B; Kaunitz AM; D'Aloisio AA; Sandler DP; Wentzensen N
JAMA; 2020 Jan; 323(1):49-59. PubMed ID: 31910280
[TBL] [Abstract][Full Text] [Related]
16. Mesothelioma Associated With the Use of Cosmetic Talc.
Moline J; Bevilacqua K; Alexandri M; Gordon RE
J Occup Environ Med; 2020 Jan; 62(1):11-17. PubMed ID: 31609780
[TBL] [Abstract][Full Text] [Related]
17. Perineal talc exposure and subsequent epithelial ovarian cancer: a case-control study.
Wong C; Hempling RE; Piver MS; Natarajan N; Mettlin CJ
Obstet Gynecol; 1999 Mar; 93(3):372-6. PubMed ID: 10074982
[TBL] [Abstract][Full Text] [Related]
18. Assessment of Health Risk from Historical Use of Cosmetic Talcum Powder.
Anderson EL; Sheehan PJ; Kalmes RM; Griffin JR
Risk Anal; 2017 May; 37(5):918-929. PubMed ID: 27393372
[TBL] [Abstract][Full Text] [Related]
19. Genital powder exposure and the risk of epithelial ovarian cancer.
Rosenblatt KA; Weiss NS; Cushing-Haugen KL; Wicklund KG; Rossing MA
Cancer Causes Control; 2011 May; 22(5):737-42. PubMed ID: 21516319
[TBL] [Abstract][Full Text] [Related]
20. Analytic comparison of talc in commercially available baby powder and in pelvic tissues resected from ovarian carcinoma patients.
Johnson KE; Popratiloff A; Fan Y; McDonald S; Godleski JJ
Gynecol Oncol; 2020 Nov; 159(2):527-533. PubMed ID: 32977988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
